On September 17, the China Medical City (CMC) Policy Release & Project Signing Ceremony was held at the CMC Conference and Exhibition Center. 30 key medical projects were officially contracted and settled in China Medical City, representing a total investment of RMB 6.74 billion.
Since its construction in 2006, the China Medical City has seen prominent synergy of key projects, and has become the main location for the development of biomedicine and high-performance medical device industry, and the driving force for the health & wellness industry in Taizhou City. A large number of well-known enterprises, first-rate talents, and cutting-edge technologies in the field of medicine gathered in CMC and realized industrialization, adding merits to CMC’s solid industrial foundation, preferential policy environment, professional service capabilities, and complete supporting facilities. A health & wellness city with distinctive pharmaceutical characteristics is accelerating its rise.
Among the 30 contracted projects, there are 26 industrialization projects, 1 regional headquarters, and 3 major supporting facilities, with distinct pharmaceutical features. The industrialization projects on food for special medical purpose, influenza vaccine, biological reagents, cellular immunotherapy, medical-grade purification equipment, bio-health products, in vitro diagnostic reagents, new medical device materials and other products, will bring not only large amounts of investment, but also high technology, and broad market prospect.